# PGE2 Levels in Patient Treated With NSAIDs

> **NCT03597867** · PHASE3 · COMPLETED · sponsor: **University of Trieste** · enrollment: 104 (actual)

## Conditions studied

- Ocular Inflammation

## Interventions

- **OTHER:** Placebo
- **DRUG:** Dicloftil
- **DRUG:** Nevanac
- **DRUG:** Indom
- **DRUG:** Yellox

## Key facts

- **NCT ID:** NCT03597867
- **Lead sponsor:** University of Trieste
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-25
- **Primary completion:** 2018-07-05
- **Final completion:** 2018-07-09
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2018-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03597867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03597867, "PGE2 Levels in Patient Treated With NSAIDs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03597867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*